Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246465.RAzuie6T-yy1SQceRBqj02cfXXy3tw7Vy76om9YhNDL9g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246465.RAzuie6T-yy1SQceRBqj02cfXXy3tw7Vy76om9YhNDL9g130_assertion type Assertion NP1246465.RAzuie6T-yy1SQceRBqj02cfXXy3tw7Vy76om9YhNDL9g130_head.
- NP1246465.RAzuie6T-yy1SQceRBqj02cfXXy3tw7Vy76om9YhNDL9g130_assertion description "[Overall, PIK3CA mutations are most commonly seen, with fewer TP53 and PTEN mutations, similar to the profile seen in luminal A female breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246465.RAzuie6T-yy1SQceRBqj02cfXXy3tw7Vy76om9YhNDL9g130_provenance.
- NP1246465.RAzuie6T-yy1SQceRBqj02cfXXy3tw7Vy76om9YhNDL9g130_assertion evidence source_evidence_literature NP1246465.RAzuie6T-yy1SQceRBqj02cfXXy3tw7Vy76om9YhNDL9g130_provenance.
- NP1246465.RAzuie6T-yy1SQceRBqj02cfXXy3tw7Vy76om9YhNDL9g130_assertion SIO_000772 25490678 NP1246465.RAzuie6T-yy1SQceRBqj02cfXXy3tw7Vy76om9YhNDL9g130_provenance.
- NP1246465.RAzuie6T-yy1SQceRBqj02cfXXy3tw7Vy76om9YhNDL9g130_assertion wasDerivedFrom befree-2016 NP1246465.RAzuie6T-yy1SQceRBqj02cfXXy3tw7Vy76om9YhNDL9g130_provenance.
- NP1246465.RAzuie6T-yy1SQceRBqj02cfXXy3tw7Vy76om9YhNDL9g130_assertion wasGeneratedBy ECO_0000203 NP1246465.RAzuie6T-yy1SQceRBqj02cfXXy3tw7Vy76om9YhNDL9g130_provenance.